Risk of Cancer After Diagnosis of Cardiovascular Disease
- PMID: 37614573
- PMCID: PMC10443115
- DOI: 10.1016/j.jaccao.2023.01.010
Risk of Cancer After Diagnosis of Cardiovascular Disease
Abstract
Background: Cardiovascular disease (CVD) and cancer share several risk factors. Although preclinical models show that various types of CVD can accelerate cancer progression, clinical studies have not determined the impact of atherosclerosis on cancer risk.
Objectives: The objective of this study was to determine whether CVD, especially atherosclerotic CVD, is independently associated with incident cancer.
Methods: Using IBM MarketScan claims data from over 130 million individuals, 27 million cancer-free subjects with a minimum of 36 months of follow-up data were identified. Individuals were stratified by presence or absence of CVD, time-varying analysis with multivariable adjustment for cardiovascular risk factors was performed, and cumulative risk of cancer was calculated. Additional analyses were performed according to CVD type (atherosclerotic vs nonatherosclerotic) and cancer subtype.
Results: Among 27,195,088 individuals, those with CVD were 13% more likely to develop cancer than those without CVD (HR: 1.13; 95% CI: 1.12-1.13). Results were more pronounced for individuals with atherosclerotic CVD (aCVD), who had a higher risk of cancer than those without CVD (HR: 1.20; 95% CI: 1.19-1.21). aCVD also conferred a higher risk of cancer compared with those with nonatherosclerotic CVD (HR: 1.11; 95% CI: 1.11-1.12). Cancer subtype analyses showed specific associations of aCVD with several malignancies, including lung, bladder, liver, colon, and other hematologic cancers.
Conclusions: Individuals with CVD have an increased risk of developing cancer compared with those without CVD. This association may be driven in part by the relationship of atherosclerosis with specific cancer subtypes, which persists after controlling for conventional risk factors.
Keywords: atherosclerosis; cardiovascular disease; epidemiology; medical claims; risk prediction.
© 2023 The Authors.
Conflict of interest statement
This research was supported, in part, by National Institutes of Health (NIH) grant CCSG P30 CA016672. Dr Bell has received an unrestricted grant from Damon Runyon Cancer Research Foundation PST 33-21 for the conduct of this study. Drs Nead and Wehner are Cancer Prevention and Research Institute of Texas (CPRIT) Scholars in Cancer Research. Dr Nead is supported by CPRIT RR190077, NCI L30CA253796, and NCI K08CA263313. Dr Wehner is supported by CPRIT FP9178 and NCI K08CA263298. Dr Giordano is supported by CPRIT RP160674 and Komen SAC150061. Dr Leeper is supported by NIH R35HL144475 and American Heart Association grant EIA34770065. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures





References
-
- Kochanek K.D., Xu J.Q., Arias E. National Center for Health Statistics; Hyattsville, MD: 2020. Mortality in the United States, 2019. NCHS Data Brief, no 395. - PubMed
-
- World Health Organization, WHO Department of Data and Analytics . World Health Organization; Geneva, Switzerland: 2020. WHO Methods and Data Sources for Global Burden of Disease Estimates, 2000-2019.